Session Details
Radioactivity measurement/Synthesis of labelled compounds and their metabolism 1/Radiopharmaceuticals/Protection and control of radiation/Others
Fri. Mar 29, 2024 8:30 AM - 12:00 PM JST
Fri. Mar 29, 2024 11:30 PM - 3:00 AM UTC
Fri. Mar 29, 2024 11:30 PM - 3:00 AM UTC
[Poster 5] Exhibition Hall AB (1F)
[29P-am163S]Evaluation of an 211At-labeled peptide targeting melanoma as a targeted α-therapy agent
○Megumi Uchiyama1, Hiroyuki Suzuki1, Shoko Tanaka1, Saki Yamashita1, Kento Kannaka1, Tomoya Uehara1 (1. Grad.Sch.Pharm.Sci.,Chiba Univ.)
[29P-am164S]211At-labeled PSMA derivative for reducing radioactivity in the kidney
○Taichi Muto1, Tomoki Yamashita2, Kento Kannaka2, Hiroyuki Suzuki2, Tomoya Uehara2 (1. Chiba Univ., 2. Grad. Sch. Pharm. Sci, Chiba Univ.)
[29P-am165S]Fundamental evaluation of the relationship between albumin-binding and tumor accumulation of PSMA-targeted radiopharmaceuticals
○Nobuki Kazuta1, Hiroyuki Watanabe1, Masahiro Ono1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
[29P-am166]Evaluation of the efficacy for a PET imaging probe targeting STAT3
○Anna Miyazaki1, Yurika Iio1, Yasukazu Kanai1, Keita Wakamori1, Serina Mizuguchi1, Mikiya Futatsugi1, Fuko Hirano1, Naoya Kondo1, Takashi Temma1 (1. Grad. Sch. Pharm. Sci., Osaka Med. Pharm. Univ.)
[29P-am167S]Synthesis and evaluation of SPECT imaging probes targeting STAT3
○Maiko Hayashi1, Anna Miyazaki1, Hiroto Takahashi1, Keita Wakamori1, Serina Mizuguchi1, Mikiya Futatsugi1, Fuko Hirano1, Naoya Kondo1, Takashi Temma1 (1. Pharm. Sci., Osaka Med. Pharm. Univ.)
[29P-am168S]Development and initial evaluation of novel functional nano particles for accelerated blood clearance (ABC) phenomenon evasion.
○Reo Takahashi1, Narumi Endo1, Kotaro Anzai1, Yuichiro Tanaka1, Yumi Yamamoto1, Yohei Saito1, Akira Makino2, Yasushi Kiyono2, Fumihiko Yamamoto1 (1. Facility of Pharmaceutical science, Tohoku Med. Pharm. Univ., 2. Biomedical Imaging Research Center, Fukui Univ.)
[29P-am169S]Evaluation of the effect of lipid charge on tumor accumulation of lipid-styrene maleic acid copolymer nanodiscs
○Tomoya Fukada1, Kohei Sano1, Masayuki Munekane2, Toshihide Yamasaki1, Masafumi Tanaka1, Takahiro Mukai1 (1. Kobe Pharm. Univ., 2. Grad. Sch. Med. Sci., Kanazawa Univ.)
[29P-am170]Development of heparanase-targeted radiopharmaceuticals to detect vulnerable plaques in atherosclerosis
○Kohei Sano1, Shiho Tanaka1, Miyu Kohira1, Naoto Sasaki1, Toru Tanaka1, Satomi Nadanaka1, Toshihide Yamasaki1, Yoshiyuki Rikitake1, Hiroshi Kitagawa1, Masayori Hagimori2, Takahiro Mukai1 (1. Kobe Pharm. Univ., 2. Sch. Pharm., Mukogawa Women's Univ.)
[29P-am171S]Development of a radiolabeled probe to evaluate the in vivo behavior of hypochlorous acid non-invasively
○Terumi Sakane1, Risa Azuma1, Toshihide Yamasaki1, Kohei Sano1, Takahiro Mukai1 (1. Kobe Pharm. Univ.)
[29P-am172]Development of a novel σ-2 receptor ligand, MILV, and basic evaluation as an imaging probe
○Takashi Kozaka1, Yoji Kitamura1, Kazuma Ogawa2, Hiroyuki Kimura1 (1. ReCEMHD, Kanazawa Univ., 2. Inst. Frontier Sci. Initiative, Kanazawa Univ.)
[29P-am173S]Development of Cherenkov-activated imaging agents
○Yuri Endo1, Atsushi Hirose1, Yoshinori Kato1 (1. Hoshi Univ.)
[29P-am174]Radiation education for junior and senior high school students using the measuring of naturally occurring radioactive materials and gamification tool
○Fujino Hideki1, Sato Yoshiko2, Shiraishi Shugo1, Hayashi Takunari1, Sakai Shuhei1 (1. Sch. Pharm., Hyogo Medical Univ., 2. Junior and Senior High Sch., Wakayama Shin-ai)
[29P-am175S]Development a novel 40 K quantification to prevent medical accident caused by potassium overdose
○Taisei Hayashi1, Miho Tkahashi1, Tsutomu Yodoshi2, Syuhei Sakai1, Hideki Fujino1,2 (1. Sch. Pharm., Hyogo Medical Univ., 2. Grad. Sch. Pharm., Hyogo Medical Univ.)
[29P-am176]Proposal of inspection method for radiation measuring instruments using commercial regents
○Shuhei Sakai1, Hideki Fujino1 (1. Sch. Pharm., Hyogo Medical Univ.)